Why is direct detection
so important?
Clinical studies funded by the NIH/NEI have shown that screening with Rebion's Blinq technology is a dramatically more accurate approach to measuring for amblyopia than methods which merely collect data on amblyopia risk factors (ARF).* Greater accuracy leads to a reduction in care costs while improving patient outcomes.
*JAMA Ophthamol. 2014;132(7):814-820.doi:10.1001/jamaophthalmol.2014.424. Published online May 29, 2014.
Amblyopia represents a syndrome of compromised deficits:
Micro Strabismus
Strabismus
Refractive Error
Decreased Depth Perception (Stereopsis)
Reduced Visual Acuity (20/40 or Greater Corrected)